Management of irritable bowel syndrome in primary care: the results of an exploratory randomised controlled trial of mebeverine, methylcellulose, placebo and a self-management website.

BMC Gastroenterol · 2013 · PMC3651308 · PMID 23602047

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

A highly significant difference was found in the Enablement scores at 6 and 12 week follow-up between the website conditions and the control group (Tables 4 and 6 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.